Anti-VEGFR therapy is one of the healing inhibitors of antiresorptive-related osteonecrosis of the jaw

ConclusionIn the conservative treatment of ARONJ, the administration of several BMAs and anti-VEGFR drugs was the factor contributing to the inhibition of healing.
Source: Journal of Bone and Mineral Metabolism - Category: Orthopaedics Source Type: research